Corient Private Wealth
KMTS

Corient Private Wealth’s Kestra Medical Technologies KMTS Stock Holding History

Corient Private Wealth’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$314K Buy
+15,775
New +$372K ﹤0.01% 2302

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Corient Private Wealth's KMTS Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Kestra Medical Technologies (KMTS) in Q1 2026: 15,775 shares worth $314K. The stake represents ﹤0.01% of the portfolio and ranks #2302 among its holdings.

103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Corient Private Wealth held 15,775 shares of Kestra Medical Technologies worth $314K as of Q1 2026.
  • Kestra Medical Technologies was a new Corient Private Wealth position in Q1 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2302 holding.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.